BDBM192450 US9187466, 42::US9687476, 42

SMILES COc1ccc(Cn2c(nn(Cc3nnc(Cc4c(Cl)cccc4Cl)[nH]3)c2=O)-c2ccc(Cl)cc2)cc1

InChI Key InChIKey=ZAWNCASKMCRQPF-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 192450   

TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  11nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  4nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  11nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent